Bulletin from the annual general meeting in Alligator Bioscience AB on June 1, 2021
Lund, Sweden, June 1, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the annual general meeting was held in the ...
Alligator’s mitazalimab shown to enhance cancer vaccine
Lund, Sweden, May 5, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that preclinical data on its agonist anti-CD40 an ...
Alligator Bioscience and BioArctic enter into research agreement in the neurodegenerative field
Lund, Sweden, May 4, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research agreeme ...
Board member in Alligator Bioscience resigns at his own request
Lund, Sweden, April 30, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company's Board member Carl Borre ...
Notice of annual general meeting in Alligator Bioscience AB
The shareholders of Alligator Bioscience AB, Reg. No. 556597-8201 (“Alligator”), are invited to the annual general meeting to be held on Tue ...
The Nomination Committee’s proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB
Ahead of the annual general meeting in Alligator Bioscience AB on June 1, 2021, the Nomination Committee announces its proposals regarding C ...
Alligator Bioscience and MacroGenics Enter into a Research Collaboration to Develop a Novel Immunotherapy
Lund, Sweden, April 15, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has entered into a joint research coll ...
Alligator Bioscience postpones the Annual General Meeting to June 1, 2021
Lund, Sweden, April 3, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the board of directors has decided to post ...
Alligator Bioscience appoints Søren Bregenholt as new CEO
Lund, Sweden, March 18, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Board of Directors has appointed Søre ...